What Does Geithner Leaving Treasury Mean for Bonds?

Jan. 3 (Bloomberg) -- Eric Stein, portfolio manager at Eaton Vance discusses what U.S. Treasury Secretary Timothy Geithner stepping down will mean to the fixed income markets. He speaks on Bloomberg Television's "Lunch Money."

Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
09:30 - Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan to sell the drug for $13,000 a month. Merck KgaA CEO Stegfan Oschmann speaks on "Bloomberg Daybreak Europe." (Source: Bloomberg)
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity
  • French Presidential Race Takes an Inflammatory Turn